Issue :

SFDA has issued a recall of one batches of Ascorbic Acid 500mg tablet due to the product is not registered with the out of specifications.

Recommendations :

For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.

For patients,

• Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
• Contact the recalling firm or SFDA if you have any questions about the recall.
• Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).